back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-07-29 16:50 Tx date 2026-07-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+1,000,000 vol |
1,000,000 | |
| Filed 2026-07-29 16:49 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-17 10:52 Tx date 2026-07-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,370
-45,500 vol $0.14 each |
134,062 | |
| Filed 2026-07-14 18:50 Tx date 2026-07-14 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,160
-16,000 vol $0.135 each |
179,562 | |
| Filed 2026-07-14 18:49 Tx date 2026-07-13 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,218
-186,800 vol $0.135 each |
195,562 | |
| Filed 2026-07-14 18:48 Tx date 2026-07-13 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42.00
-300 vol $0.14 each |
382,362 | |
| Filed 2026-07-14 18:47 Tx date 2026-07-10 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-224.00
-1,600 vol $0.14 each |
382,662 | |
| Filed 2026-07-14 18:46 Tx date 2026-07-10 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,934.63
-21,738 vol $0.135 each |
384,262 | |
| Filed 2026-06-17 15:40 Tx date 2026-06-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,000
+100,000 vol $0.10 each |
406,000 | |
| Filed 2026-06-17 15:39 Tx date 2026-06-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
350,000 | |
| Filed 2026-06-17 15:30 Tx date 2026-06-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+150,000 vol $0.10 each |
700,000 | |
| Filed 2026-06-17 15:29 Tx date 2026-06-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-150,000 vol |
450,000 | |
| Filed 2026-06-12 13:29 Tx date 2026-06-10 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$17,500
+175,000 vol $0.10 each |
6,077,778 | |
| Filed 2026-06-12 13:28 Tx date 2026-06-10 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-17,500
-175,000 vol $0.10 each |
3,000,000 | |
| Filed 2026-05-21 14:21 Tx date 2026-05-08 |
$MDMA
Pharmala Biotech Holdings Inc. |
Ryer, Lennie
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,400
+36,000 vol $0.15 each |
36,000 | |
| Filed 2026-05-21 14:20 Tx date 2026-02-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Ryer, Lennie
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-15 10:58 Tx date 2026-05-14 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,000
+100,000 vol $0.10 each |
456,000 | |
| Filed 2026-05-15 10:58 Tx date 2026-05-14 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-10,000
-100,000 vol $0.10 each |
350,000 | |
| Filed 2026-04-30 13:04 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
5,902,778 | |
| Filed 2026-04-30 13:04 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
0 |